Clinical scales for multiple sclerosis

[1]  J. Koziol,et al.  Cladribine in treatment of chronic progressive multiple sclerosis , 1994, The Lancet.

[2]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[3]  R. Heaton,et al.  Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. , 1985, Journal of consulting and clinical psychology.

[4]  R. Heaton,et al.  Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis , 1988, Neurology.

[5]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[6]  R. Slater.  Criteria and uses of the Minimal Record of Disability in multiple sclerosis , 1984, Acta neurologica Scandinavica. Supplementum.

[7]  R. Kikinis,et al.  Longitudinal MRI in multiple sclerosis , 1994, Neurology.

[8]  H. Weiner,et al.  A working protocol to be used as a guideline for trials in multiple sclerosis. , 1983, Archives of neurology.

[9]  J. Kurtzke.  A New Scale for Evaluating Disability in Multiple Sclerosis , 1955, Neurology.

[10]  J. Noseworthy.  Clinical scoring methods for multiple sclerosis , 1994, Annals of neurology.

[11]  D. Goodkin,et al.  Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. , 1988, Archives of physical medicine and rehabilitation.

[12]  P M Matthews,et al.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.

[13]  C Confavreux,et al.  EDMUS, a European database for multiple sclerosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[14]  D. Bourdette,et al.  Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS) , 1992, Neurology.

[15]  L. Alexander.  New concept of critical steps in course of chronic debilitating neurologic disease in evaluation of therapeutic response; a longitudinal study of multiple sclerosis by quantitative evaluation of neurologic involvement and disability. , 1951, A.M.A. archives of neurology and psychiatry.

[16]  J. Kurtzke,et al.  On the evaluation of disability in multiple sclerosis , 1961, Neurology.

[17]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[18]  R. Rudick,et al.  Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials. , 1989, Archives of neurology.

[19]  D. Paty,et al.  Assessing the Outcome of Experimental Therapies in Multiple Sclerosis Patients , 1992 .

[20]  W. Tourtellotte,et al.  Training examiners to administer a quantitative neurological examination for a multicenter clinical trial. , 1975, Archives of physical medicine and rehabilitation.

[21]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[22]  A. Strong,et al.  Extracellular potassium activity, evoked potential and rCBF during experimental cerebral ischaemia in the baboon. , 1981, Acta neurologica Scandinavica. Supplementum.

[23]  R. J. Slater.  Scoring techniques and problems in the evaluation of change in patients. , 1983, Archives of neurology.

[24]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[25]  J. Stevens,et al.  Multiple sclerosis: MRI and clinical correlation. , 1986, AJR. American journal of roentgenology.

[26]  D. Paty,et al.  MS COSTAR: A computerized patient record adapted for clinical research purposes , 1994, Annals of neurology.

[27]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[28]  H. Weiner,et al.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. , 1983, The New England journal of medicine.

[29]  S. Weinberg,et al.  Tetraethylammonium chloride in the treatment of multiple sclerosis. , 1950, A.M.A. archives of neurology and psychiatry.

[30]  C. Wolfson,et al.  The inter-rater reliability and construct validity of the Functional Independence Measure for multiple sclerosis subjects , 1994 .

[31]  R. Knobler,et al.  A neurologic rating scale (NRS) for use in multiple sclerosis , 1984, Neurology.

[32]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[33]  Wayne A. Gordon,et al.  Characteristics and comparisons of functional assessment indices: Disability Rating Scale, Functional Independence Measure, and Functional Assessment Measure. , 1993 .

[34]  A. Thompson,et al.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.

[35]  C. Granger,et al.  Functional assessment scales: a study of persons with multiple sclerosis. , 1990, Archives of physical medicine and rehabilitation.

[36]  D. Goldberg,et al.  A scaled version of the General Health Questionnaire , 1979, Psychological Medicine.

[37]  M. Roberts,et al.  The prevalence of cognitive impairment in a community survey of multiple sclerosis. , 1991, The British journal of clinical psychology.

[38]  A V Swan,et al.  An assessment of disability rating scales used in multiple sclerosis. , 1991, Archives of neurology.

[39]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[40]  W. Beatty,et al.  Metamemory in multiple sclerosis. , 1991, Journal of clinical and experimental neuropsychology.

[41]  D. Paty,et al.  Scales for rating impairment in multiple sclerosis , 1988, Neurology.

[42]  K. Syndulko,et al.  Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. , 1990, Archives of neurology.

[43]  E. Kaplan,et al.  Guidelines for neuropsychological research in multiple sclerosis. , 1990, Archives of neurology.

[44]  H. McFarland,et al.  Outcomes assessment in multiple sclerosis clinical trials: a critical analysis , 1995, Multiple sclerosis.

[45]  S. Medendorp,et al.  Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis , 1995, Annals of neurology.

[46]  P. Parizel,et al.  Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol , 1990, Journal of the Neurological Sciences.

[47]  R. Schiffer,et al.  Affective disorders in multiple sclerosis. Review and recommendations for clinical research. , 1990, Archives of neurology.

[48]  V. Mathiowetz,et al.  Adult norms for the Box and Block Test of manual dexterity. , 1985, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[49]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[50]  Marcus J. Fuhrer,et al.  Rehabilitation outcomes : analysis and measurement , 1987 .

[51]  C. Confavreux.  Establishment and use of multiple sclerosis registers—EDMUS , 1994, Annals of neurology.

[52]  A. Strauss.  ACETYLCHOLINE-RECEPTOR-BLOCKING FACTOR AND STRIATED-MUSCLE ANTIBODY IN MYASTHENIA GRAVIS , 1976, The Lancet.

[53]  E J Orav,et al.  Disease Steps in multiple sclerosis , 1995, Neurology.

[54]  M. R. Mickey,et al.  A placebo‐controlled, randomized, double‐masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis , 1989, Neurology.

[55]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[56]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[57]  D. Miller,et al.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.

[58]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[59]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[60]  V. Mathiowetz,et al.  Adult Norms for the Nine Hole Peg Test of Finger Dexterity , 1985 .

[61]  D. Goodkin,et al.  Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. , 1990, Archives of neurology.

[62]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[63]  L. Fratiglioni,et al.  Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. , 1988, Archives of neurology.

[64]  A J Thompson,et al.  Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.

[65]  Potvin Ar,et al.  The neurological examination: advancements in its quantification. , 1975 .

[66]  M. Lavenhar,et al.  EFFECT OF TOTAL LYMPHOID IRRADIATION IN CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS , 1986, The Lancet.

[67]  M. R. Mickey,et al.  An illness severity score for multiple sclerosis , 1984, Neurology.

[68]  B. Hamilton.  A uniform national data system for medical rehabilitation. , 1987 .

[69]  K. Syndulko,et al.  Design strategies in multiple sclerosis clinical trials , 1994 .

[70]  D. Miller,et al.  Magnetic resonance in monitoring the treatment of multiple sclerosis , 1994, Annals of neurology.